Ct of interest: none declared.14. 15.16.17. 18. 19.REFERENCES 1. Kolonel LN. Fat, meat, and prostate cancer. Epidemiol Rev. 2001;23(1):72?1. two. Astorg P. Dietary n-6 and n-3 polyunsaturated fatty acids and prostate cancer danger: a overview of epidemiological and experimental proof. Cancer Causes Handle. 2004;15(4): 367?86. three. Rose DP. Effects of dietary fatty acids on breast and prostate cancers: evidence from in vitro experiments and animal studies. Am J Clin Nutr. 1997;66(6 suppl): 1513S?522S. four. De Caterina R. n-3 Fatty acids in cardiovascular illness. N Engl J Med. 2011;364(25):2439?450. 5. Catala A. A synopsis of the procedure of lipid peroxidation because the discovery with the essential fatty acids. Biochem Biophys Res Commun. 2010;399(three):318?23. six. Trzeciak AR, Nyaga SG, Jaruga P, et al. Cellular repair of oxidatively induced DNA base lesions is defective in prostate cancer cell lines, PC-3 and DU-145. Carcinogenesis. 2004; 25(eight):1359?370. 7. Khandrika L, Kumar B, Koul S, et al. Oxidative pressure in prostate cancer. Cancer Lett. 2009;282(2):125?36. eight. Forsberg L, de Faire U, Morgenstern R.2,6-Pyridinedicarboxaldehyde web Oxidative tension, human genetic variation, and disease. Arch Biochem Biophys. 2001;389(1):84?3. 9. Spickett CM, Jerlich A, Panasenko OM, et al. The reactions of hypochlorous acid, the reactive oxygen species made by myeloperoxidase, with lipids. Acta Biochim Pol. 2000; 47(four):889?99. ten. Piedrafita FJ, Molander RB, Vansant G, et al. An Alu element in the myeloperoxidase promoter consists of a composite SP1thyroid hormone-retinoic acid response element. J Biol Chem. 1996;271(24):14412?4420. 11. Choi JY, Neuhouser ML, Barnett MJ, et al. Iron intake, oxidative stress-related genes (MnSOD and MPO) and prostate cancer threat in CARET cohort. Carcinogenesis. 2008;29(five): 964?70. 12. Cheng TY, Barnett MJ, Kristal AR, et al. Genetic variation in myeloperoxidase modifies the association of serum alphatocopherol with aggressive prostate cancer amongst present smokers. J Nutr. 2011;141(9):1731?737. 13. King IB, Kristal AR, Schaffer S, et al. Serum trans-fatty acids are related with risk of prostate cancer in -Carotene and20.21.22. 23.24.25.26.27.28.29.30.Retinol Efficacy Trial. Cancer Epidemiol Biomarkers Prev. 2005;14(four):988?92. Smith BK, Robinson LE, Nam R, et al. Trans-fatty acids and cancer: a mini-review. Br J Nutr. 2009;102(9):1254?266. Omenn GS, Goodman GE, Thornquist MD, et al. Effects of a combination of beta carotene and vitamin A on lung cancer and cardiovascular disease. N Engl J Med. 1996;334(18): 1150?155. Choi JY, Neuhouser ML, Barnett M, et al. Polymorphisms in oxidative stress-related genes are not linked with prostate cancer risk in heavy smokers. Cancer Epidemiol Biomarkers Prev. 2007;16(6):1115?120. Folch J, Lees M, Sloane Stanley GH. A straightforward strategy for the isolation and purification of total lipids from animal tissues.Price of 1355070-36-8 J Biol Chem.PMID:23255394 1957;226(1):497?09. Lepage G, Roy CC. Direct transesterification of all classes of lipids within a one-step reaction. J Lipid Res. 1986;27(1): 114?20. Ambrosone CB, Ahn J, Singh KK, et al. Polymorphisms in genes related to oxidative anxiety (MPO, MnSOD, CAT) and survival immediately after therapy for breast cancer. Cancer Res. 2005; 65(three):1105?111. Mikhak B, Hunter DJ, Spiegelman D, et al. Manganese superoxide dismutase (MnSOD) gene polymorphism, interactions with carotenoid levels and prostate cancer danger. Carcinogenesis. 2008;29(12):2335?340. Shui IM, Mucci LA, Kraft P, et al. Vitamin D-related genetic variation, plasma v.